Shilpak Chatterjee

2.0k citations

40 papers · 947 indexed · h-index 18

Impact in

Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Atherosclerosis and Cardiovascular Diseases
- Immunotherapy and Immune Responses
Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Metal complexes synthesis and properties

Papers in

Physiology 5
Immunology 17
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 5

Co-authors: Shikhar Mehrotra Soumitra Kumar Choudhuri Paramita Chakraborty Jonathan M. Eby I. Caroline Le Poole Mitali Chatterjee Thomas Efferth Smarajit Pal
Journals: BioMetals (3 papers)The Journal of Immunology (3 papers)Cancer Research (3 papers)Journal of Clinical Investigation (2 papers)Journal of Investigative Dermatology (2 papers)
Partner nations: United States India Germany

In The Last Decade

Shilpak Chatterjee

36 papers receiving 941 citations

Peers

Countries citing papers authored by Shilpak Chatterjee

Since Specialization

Citations

This map shows the geographic impact of Shilpak Chatterjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilpak Chatterjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilpak Chatterjee more than expected).

Fields of papers citing papers by Shilpak Chatterjee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilpak Chatterjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilpak Chatterjee. The network helps show where Shilpak Chatterjee may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shilpak Chatterjee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shilpak Chatterjee Line = papers co-authored together Shilpak Chatterjee links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumor Science Advances ·Ishita Sarkar, Caputi Luigi, W. Zhang, Anupam Gautam, Tian Yang Ooi, Praveen Singh, Л.А. Павлова, Д.А. Манукян, L.M.J. Nijsten, 陽一野尻, Eze Nkechi Gift, Ramanuj Mukherjee, Shikhar Mehrotra, Almos I. Kovacs, Shantanu Sengupta, Sandip Paul, Shilpak Chatterjee	2025	2
2	Unravelling the modes of phototoxicity of NIR absorbing chlorophyll derivative in cancer cells under normoxic and hypoxic conditions Photochemical & Photobiological Sciences ·Shilpak Chatterjee, Alok Dube, Shovan Kumar Majumder	2025	1
3	The hypoxia-induced chromatin reader ZMYND8 drives HIF-dependent metabolic rewiring in breast cancer Journal of Biological Chemistry ·藤彦西島, Elif Gürkan, Haiying Yuan, Zhang Yalan, Indranil Banerjee, Shantanu Ghosh, S Shokuhi, B. A. Onusaitis, 游鎮烽, 治雄小泉, Sanghamitra Sengupta, Shilpak Chatterjee, Chandrima Das	2025	0
4	Intratumoral PD1+CD38+Tim3+ CD8+ T Cells in Pre-BCG Tumor Tissues Are Associated with Poor Responsiveness to BCG Immunotherapy in Patients with Non-Muscle Invasive Bladder Cancer Cells ·Caputi Luigi, Eze Nkechi Gift, Cornelius Willet Gillam Hyde, Donald G. Farr, Haiying Yuan, Mengxian Luo, Tian Yang Ooi, L.M.J. Nijsten, Dilip Kumar Pal, Shilpak Chatterjee	2023	3
5	Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19 Gut Pathogens ·Báez Ortiz, Purbita Bandopadhyay, Yogiraj Ray, Mira Fitriana, Jafar Sarif, Ranit D’Rozario, Abhishake Lahiri, Santanu Das, Iulia Sevciuc, Shilpak Chatterjee, Bhabatosh Das, Dipyaman Ganguly	2023	8
6	Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19 Viruses ·Ranit D’Rozario, Deblina Raychaudhuri, Purbita Bandopadhyay, Jafar Sarif, Priyanka Mehta, Chinky Shiu Chen Liu, Kunpeng Song, 林珊, Sabine Caillault Voyer, Monidipa Das, Sanghamitra Bandyopadhyay, Mira Fitriana, Shilpak Chatterjee, Rajesh Pandey, Yogiraj Ray, Dipyaman Ganguly	2023	6
7	Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells Cancer Research ·L.M.J. Nijsten, Л.А. Павлова, Марина Игоревна Высоцкая, Anupam Gautam, Caputi Luigi, Haiying Yuan, W. Zhang, Donald G. Farr, Abraham Santillán, Paramita Chakraborty, Asima Mukhopadhyay, Shikhar Mehrotra, Soumen Basak, Sandip Paul, Shilpak Chatterjee	2022	38
8	Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19 SHILAP Revista de lepidopterología ·Deblina Raychaudhuri, Purbita Bandopadhyay, Ranit D’Rozario, Jafar Sarif, Yogiraj Ray, Mira Fitriana, Praveen Singh, Kausik Chaudhuri, Sabine Caillault Voyer, Rajesh Pandey, Prasun Bhattacharya, Shantanu Sengupta, Shilpak Chatterjee, Dipyaman Ganguly	2022	4
9	A prospective study on COVID‐19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre ISBT Science Series ·Somasundaram Somasundaram, W. T., Fritz Romann, R. Sakukawa, 林尤超, Sahni D. P. Skom. MMSi Sahni D. P. Skom. MMSi, Arijit Das, Pier-Alberto Testoni, Yogiraj Ray, Alba Martínez Alonso, 佐藤千絵, Bibhuti Saha, Sandip Paul, Shilpak Chatterjee, Dipyaman Ganguly, Prasun Bhattacharya	2021	3
10	Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response Clinical Cancer Research ·Shilpak Chatterjee, Paramita Chakraborty, Anusara Daenthanasanmak, Supinya Iamsawat, Gabriela Andrejeva, 栄美子竹内, Melissa M. Wolf, J J Hong, Carsten Krieg, Craig C. Beeson, Meenal Mehrotra, Elizabeth G. Hill, Jeffery C. Rathmell, Xue‐Zhong Yu, Andrew S. Kraft, Shikhar Mehrotra	2018	43
11	PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity Journal of Clinical Investigation ·Anusara Daenthanasanmak, Yongxia Wu, Supinya Iamsawat, Hung Nguyen, David Bastian, 玉利正文, M. Hanief Sofi, Shilpak Chatterjee, Elizabeth G. Hill, Shikhar Mehrotra, Andrew S. Kraft, Xue‐Zhong Yu	2018	27
12	CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo Journal of Investigative Dermatology ·Jonathan M. Eby, Hee-Kap Kang, Hirofumi Tamenaga, Wendy Bindeman, Daniel S. Peiffer, Shilpak Chatterjee, Shikhar Mehrotra, I. Caroline Le Poole	2015	62
13	Anti-oxidant capacity and anti-tumor T cell function: A direct correlation OncoImmunology ·Pravin Kesarwani, Keerthanna Govindarajan Santhakumar, Shilpak Chatterjee, Viswanathan Palanisamy, Shikhar Mehrotra	2015	9
14	Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of Tumors Cancer Research ·Shilpak Chatterjee, Keerthanna Govindarajan Santhakumar, Pravin Kesarwani, Jin H. Song, Shuiyuan Yang, Jianing Fu, Stefanie R. Bailey, F.J. Marotta, Andrew S. Kraft, Chrystal M. Paulos, Xue‐Zhong Yu, Shikhar Mehrotra	2014	46
15	Interferon-Gamma (IFN-γ)-Mediated Retinal Ganglion Cell Death in Human Tyrosinase T Cell Receptor Transgenic Mouse PLoS ONE ·Shahid Husain, Yasir Abdul, Christine Webster, Shilpak Chatterjee, Pravin Kesarwani, Shikhar Mehrotra	2014	11
16	A Quantitative Increase in Regulatory T Cells Controls Development of Vitiligo Journal of Investigative Dermatology ·Shilpak Chatterjee, Jonathan M. Eby, Amir A. Al-Khami, Shuiyuan Yang, Hee-Kap Kang, Hu Lai-zhao, Osama Naga, Anuradha K. Murali, Michael I. Nishimura, I. Caroline Le Poole, Shikhar Mehrotra	2013	83
17	Myeloid derived suppressor cells (MDSCs) can induce the generation of Th17 response from naïve CD4+ T cells Immunobiology ·Shilpak Chatterjee, Satyajit Das, Paramita Chakraborty, Alak Manna, Mitali Chatterjee, Soumitra Kumar Choudhuri	2012	40
18	Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo BioMetals ·Sudipto Ganguly, Paramita Chakraborty, Kaushik Banerjee, Shilpak Chatterjee, Soumya Basu, Avijit Sarkar, Mitali Chatterjee, Soumitra Kumar Choudhuri	2011	12
19	The role of copper in drug-resistant murine and human tumors BioMetals ·Chen Yuan-fen, Shilpak Chatterjee, Smarajit Pal, Hugo Espinosa-Jiménez, Thomas Efferth, Soumitra Kumar Choudhuri	2008	66
20	A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo BMC Cancer ·Ananda Mookerjee, Jayati Basu, Chen Yuan-fen, Shilpak Chatterjee, Aydın Ipek, Pranabananda Dutta, Smarajit Pal, Tanja Kasten, Thomas Efferth, Syamal Roy, Soumitra Kumar Choudhuri	2006	67

About Shilpak Chatterjee

Shilpak Chatterjee is a scholar working on Physiology, Immunology, Oncology, Toxicology and Nutrition and Dietetics, having authored 40 papers that have together received 947 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (9 papers), CAR-T cell therapy research (7 papers), Drug Transport and Resistance Mechanisms (6 papers), T-cell and B-cell Immunology (5 papers), COVID-19 Clinical Research Studies (4 papers), Trace Elements in Health (4 papers), Metal complexes synthesis and properties (4 papers) and melanin and skin pigmentation (4 papers). The work is most often cited by research in Immunology (415 citations), Oncology (307 citations), Physiology (49 citations), Cell Biology (148 citations) and Hematology (77 citations). Shilpak Chatterjee has collaborated with scholars based in United States, India and Germany. Frequent co-authors include Shikhar Mehrotra, Soumitra Kumar Choudhuri, Paramita Chakraborty, Jonathan M. Eby, I. Caroline Le Poole, Mitali Chatterjee, Thomas Efferth, Smarajit Pal, Hee-Kap Kang and Xue‐Zhong Yu. Their work appears in journals such as BioMetals, The Journal of Immunology, Cancer Research, Journal of Clinical Investigation and Journal of Investigative Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact